Stay updated with breaking news from Generation Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
- Immune-quiet DNA evades innate immune sensors in both mice and non-human primates addressing a central challenge for non-viral DNA therapeutics - Proprietary cell-targeted LNP delivery system...
70% of circulating and splenic T cells positive for mRNA expression in humanized mice with less than 8% delivery to off-target immune cells Stealth...
70% of circulating and splenic T cells positive for mRNA expression in humanized mice with less than 8% delivery to off-target immune cells Stealth properties of cell-targeted lipid nanoparticle ...
TODAY’S GAME PLAN: from the trading desk, this is not research DATA/HEADLINES 8:30ET Chicago Fed Nat Activity Index TODAY’S HIGHLIGHTS: California Governor Gavin Newsom is in China for weeklong trip Nine Republicans are running for House speaker 3 Chinese firms used parts of leopards and pangolins as ingredients in medicine products Global stocks
TD Cowen lowered shares of Generation Bio (NASDAQ:GBIO – Free Report) from an outperform rating to a market perform rating in a research report sent to investors on Thursday, Marketbeat.com reports. A number of other analysts have also recently commented on GBIO. Needham & Company LLC reaffirmed a buy rating and set a $14.00 price […]